StockData
enVVeno Medical Corp logo

enVVeno Medical Corp (NVNO) stock

NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$5.77+0.00 (0.00%)

Close on Nov 18, 2026Market cap $4.01MP/E –Yield –

enVVeno Medical total assets

Total assets on the balance sheet at the end of each period.

enVVeno Medical's total assets was $19.49M at Sep 30, 2026. For fiscal 2025 it was $29.56M, down 34.2% from the year before. The highest annual figure on record is $57.70M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$29.56M-34.2%
FY2024Dec 31, 2024$44.95M-7.6%
FY2023Dec 31, 2023$48.64M+16.7%
FY2022Dec 31, 2022$41.66M-27.8%
FY2021Dec 31, 2021$57.70M+447.5%
FY2020Dec 31, 2020$10.54M+206.8%
FY2019Dec 31, 2019$3.43M-3.5%
FY2018Dec 31, 2018$3.56M+60.7%
FY2017Dec 31, 2017$2.21M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$19.49M-39.8%
Q2 FY2026Jun 30, 2026$22.66M-38.0%
Q1 FY2026Mar 31, 2026$26.10M-35.7%
Q4 FY2025Dec 31, 2025$29.56M-34.2%
Q3 FY2025Sep 30, 2025$32.35M-35.8%
Q2 FY2025Jun 30, 2025$36.58M-10.8%
Q1 FY2025Mar 31, 2025$40.58M-9.5%
Q4 FY2024Dec 31, 2024$44.95M-7.6%
Q3 FY2024Sep 30, 2024$50.39M+79.4%
Q2 FY2024Jun 30, 2024$41.00M+27.8%
Q1 FY2024Mar 31, 2024$44.83M+22.4%
Q4 FY2023Dec 31, 2023$48.64M+16.7%
Q3 FY2023Sep 30, 2023$28.09M-38.2%
Q2 FY2023Jun 30, 2023$32.09M-35.7%
Q1 FY2023Mar 31, 2023$36.61M-32.5%
Q4 FY2022Dec 31, 2022$41.66M-27.8%
Q3 FY2022Sep 30, 2022$45.46M-23.2%
Q2 FY2022Jun 30, 2022$49.93M+17.9%
Q1 FY2022Mar 31, 2022$54.22M+20.4%
Q4 FY2021Dec 31, 2021$57.70M+447.5%
Q3 FY2021Sep 30, 2021$59.17M+740.2%
Q2 FY2021Jun 30, 2021$42.35M+1034.4%
Q1 FY2021Mar 31, 2021$45.05M+1526.7%
Q4 FY2020Dec 31, 2020$10.54M+206.8%
Q3 FY2020Sep 30, 2020$7.04M+22.5%
Q2 FY2020Jun 30, 2020$3.73M-48.5%
Q1 FY2020Mar 31, 2020$2.77M-49.5%
Q4 FY2019Dec 31, 2019$3.43M-3.5%
Q3 FY2019Sep 30, 2019$5.75M+5.8%
Q2 FY2019Jun 30, 2019$7.25M+0.7%
Q1 FY2019Mar 31, 2019$5.49M+147.8%
Q4 FY2018Dec 31, 2018$3.56M–
Q3 FY2018Sep 30, 2018$5.44M–
Q2 FY2018Jun 30, 2018$7.21M–
Q4 FY2017Dec 31, 2017$2.21M–

More enVVeno Medical figures

See a number that looks wrong?